Welcome Back |Sign in | Register
Your Position: Home > Pharmaceutical > Api > Capmatinib
Products Category

View History

Capmatinib
prev zoom next

Name:Capmatinib

  • Catalog No.:
  • BCM005892
  • Chem Name:
  • Capmatinib
  • Synonym:
  • Capmatinib; INC280, INCB 28060; NVP-INC280; INC 280; INCB028060; NVP INC280; INCB28060; INCB-28060; NVPINC280; INC280; INC-280; INCB-028060; INCB 028060;
  • CAS No.:
  • 1029712-80-8
  • Formula:
  • C23H17FN6O
  • Molecular:
  • 412.42
  • Storage:
  • Sealed storage
  • Wish  | Compare  | Referral bonuses
SKU Specification Brand Prices Stock Quantity Cart
BCM005892-250MG 250mg, Purity:98% BCM $224 2 Add Cart
BCM005892-500MG 500mg, Purity:98% BCM $352 2 Add Cart
BCM005892-1G 1g, Purity:98% BCM $610 2 Add Cart
BCM005892-5G 5g, Purity:98% BCM $1581 2 Add Cart
For more quantities, please contact telephone:0755-85269922,Or send an email to:sales@biochemmall.com

Product Description

Attribute

Goods Tag

Related Products

Description: Capmatinib (formerly also known as INCB-28060; INC280; Tabrecta) is a novel, potent, orally bioavailable, ATP-competitive inhibitor of c-MET with potential antitumor activity. It inhibits c-MET with an IC50 of 0.13 nM in a cell-free assay, and is inactive against RONβ, as well as EGFR and HER-3. Capmatinib has gained approval for the treatment of adults with metastatic non-small cell lung cancer. c-Met inhibitor INC280 selectively binds to c-Met, thereby inhibiting c-Met phosphorylation and disrupting c-Met signal transduction pathways. This may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. 

Attribute
[Chem Name] Capmatinib
[Synonym] Capmatinib; INC280, INCB 28060; NVP-INC280; INC 280; INCB028060; NVP INC280; INCB28060; INCB-28060; NVPINC280; INC280; INC-280; INCB-028060; INCB 028060;
[CAS No.] 1029712-80-8
[Formula] C23H17FN6O
[Molecular] 412.42
[Storage] Sealed storage

Goods Tag

User Comment(Total0User Comment Num)

  • No comment
Total 0 records, divided into1 pages. First Prev Next Last
Username: Anonymous user
E-mail:
Rank:
Content:
Verification code: captcha